Related Experiment Videos
Virtual darwinian drug design: QSAR inverse problem, virtual combinatorial chemistry, and computational screening
1Unidad de Investigación de Diseño de Fármacosy Conectividad Molecular, Facultad de Farmacia, Universitat de València, Spain. julian@goya.combios.es
Combinatorial Chemistry & High Throughput Screening
|May 29, 2001
Summary
Darwinian drug design methods generate and select molecular diversity, mimicking evolution. Inverse quantitative structure-activity relationship (QSAR) models computationally generate and screen chemical structures for drug discovery.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Drug Discovery
Background:
- Evolutionary principles of diversity generation and selection are mirrored in modern drug design.
- Drug design methodologies can be broadly categorized into "Darwinian" (diversity-based) and structure-based approaches.
- Quantitative Structure-Activity Relationship (QSAR) models are crucial for predicting molecular properties.
Purpose of the Study:
- To review graph theoretical approaches in drug design.
- To highlight "Darwinian" methods, including inverse QSAR, virtual combinatorial synthesis, and virtual screening.
- To provide a survey of other simulation methods in drug design.
Main Methods:
- Focus on graph theoretical drug design.
- Discussion of inverse QSAR for computational generation and selection of chemical structures.
- Exploration of virtual combinatorial synthesis and virtual screening concepts.
Main Results:
- Darwinian methods, exemplified by inverse QSAR, offer a distinct paradigm from structure-based drug design.
- Virtual combinatorial synthesis enables the computational generation of large virtual libraries.
- Virtual screening facilitates the selection of promising compounds from these libraries for synthesis and testing.
Conclusions:
- "Darwinian" drug design, utilizing computational generation and selection, is a powerful strategy.
- Graph theoretical approaches and simulation methods are integral to modern drug discovery pipelines.
- The integration of virtual synthesis and screening accelerates the identification of novel drug candidates.